Table 4.
Treatment | TPA group | Control group |
---|---|---|
Cardiac disease | Furosemide (n = 11), oxygen (n = 4), pimobendan (n = 3), thoracocentesis (n = 1), lidocaine (n = 1), sotalol (n = 1), dobutamine (n = 1) | Furosemide (n = 19), oxygen (n = 5), aural nitroglycerin (n = 4), dobutamine (n = 3), enalapril (n = 2), pimobendan (n = 2), atenolol (n = 1), benazepril (n = 1) |
Pain medication | Methadone (n = 10), fentanyl (n = 6), buprenorphine (n = 4), morphine (n = 3) | Morphine (n = 19), fentanyl (n = 14), methadone (n = 10), butorphanol (n = 6), lidocaine (n = 5), buprenorphine (n = 4), ketamine (n = 1), hydromorphone (n = 1) |
Anticoagulant | Enoxaparin (n = 6), unfractionated heparin (n = 5) | Unfractionated heparin (n = 13), enoxaparin (n = 9), nadroparin (n = 8) |
Antiplatelet | Clopidogrel (n = 9), aspirin/clopidogrel (n = 7) | Clopidogrel (n = 13), aspirin (n = 5), aspirin/clopidogrel (n = 5) |
Miscellaneous | Acepromazine (n = 7), mirtazapine (n = 2), methimazole (n = 1), intravenous fluid therapy (n = 1), ondansetron (n = 1), metronidazole (n = 1), clindamycin (n = 1), silymarin/S-adenosyl (n = 1), ursodiol (n = 1), fluconazole (n = 1), amoxicillin/clavulanic acid (n = 1), diazepam (n = 1), tolfenamic acid (n = 1) | Acepromazine (n = 5), albuterol (n = 2), intravenous fluids (n = 2), sodium bicarbonates (n = 2), antibiotics (n = 2), calcium gluconate (n = 1), insulin/dextrose (n = 1), ondansetron (n = 1), maropitant (n = 1), meloxicam (n = 1), mirtazapine (n = 1), midazolam (n = 1), surgical thrombectomy (n = 1) |
Treatments may add up to more than the total number of cats in each group because of multimodal treatment or change of medications during hospitalization
TPA = tissue plasminogen activator